The CRISPR patent battle is back on as UC Berkeley files an appeal

 The University of California Berkeley has filed an appeal in a heated CRISPR patent interference case that ruled in the Broad Institute of MIT and Harvard’s favor last earlier this year. Last year, the U.S. Patent Office started looking into whether or not the Broad Institute had the right to a separate patent for CRISPR-Cas9, which allowed for human use of the technology. Berkeley… Read More
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.